0 (0%)		12-26 19:26
Open: High: Volume: 0		Pre. Close: Low: Market Cap: 0(M)

Short term
Mid term
Targets	6-month :	45.16	1-year :	52.75
Resists	First :	38.66	Second :	45.16
Pivot price	36.83
Supports	First :	34.64	Second :	32.15
MAs	MA(5) :	37	MA(20) :	36.14
	MA(100) :	31.75	MA(250) :	0
MACD	MACD :	1.2	Signal :	1.3
%K %D	K(14,3) :	58.8	D(3) :	65.2
RSI	RSI(14): 61.9
52-week	High :	38.66	Low :	21.1

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ CBL ] has closed above bottom band by 47.5%. Bollinger Bands are 5.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	37.29 - 37.48	37.48 - 37.62
Low:	36 - 36.26	36.26 - 36.46
Close:	36.41 - 36.79	36.79 - 37.1

Wed, 24 Dec 2025
Caliway's Fat Reduction Drug Candidate CBL-514 Completes U.S. FDA IND Submission for Phase 2 Clinical Study in Weight Management, Expanding Development Combined with GLP-1RA-Based Weight-Loss Therapies - PR Newswire

Wed, 24 Dec 2025
CBL authorises activation of money transfers through the stalled MoneyGram and Western Union systems - Libya Herald

Sun, 21 Dec 2025
CBL & Associates Properties (CBL): Valuation Check After New Buyback Plan and $158 Million Refinancing Move - simplywall.st

Thu, 18 Dec 2025
CBL & Associates Properties stock hits 52-week high at $38.35 - Investing.com

Fri, 07 Nov 2025
CBL & Associates Properties (CBL) Is Up 10.9% After Strong Q3 Results and Primark Debut—Has The Bull Case Changed? - Yahoo Finance

Tue, 07 Oct 2025
E3 Ubiquitin ligases Cbl-b and c-Cbl maintain the homeostasis of macrophages by regulating the M-CSF/M-CSFR signaling axis | Cell Death & Disease - Nature

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange:
Sector:
Industry:
Shares Out	31 (M)
Shares Float	15 (M)
Held by Insiders	11.7 (%)
Held by Institutions	78.1 (%)
Shares Short	900 (K)
Shares Short P.Month	922 (K)

EPS	4
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	11.42
Profit Margin	22.5 %
Operating Margin	22.6 %
Return on Assets (ttm)	3.2 %
Return on Equity (ttm)	38.5 %
Qtrly Rev. Growth	11.3 %
Gross Profit (p.s.)	11.6
Sales Per Share	18.04
EBITDA (p.s.)	9.81
Qtrly Earnings Growth	361.1 %
Operating Cash Flow	216 (M)
Levered Free Cash Flow	194 (M)

PE Ratio	9.18
PEG Ratio	0
Price to Book value	3.21
Price to Sales	2.03
Price to Cash Flow	5.22

Dividend	0.44
Forward Dividend	0
Dividend Yield	1.2%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.